All Biotech News

	> GATC Biotech Sequences Pediatric Brain Tumors for the International Cancer Genome Consortium (ICGC)	05/18/10
	> Elexopharm Enters Into Cardiovascular Collaboration With Merck & Co., Inc	05/17/10
	> BIOTECHNICA 2010: From Biomedicine Industry to the Future of Our Food	05/12/10
	> Biotage Announces Research Collaboration with University of Copenhagen for Peptide Synthesis	05/12/10
	> COTI-2 Receives Favourable Independent Pre-Investigational New Drug Gap Analysis Report	05/11/10
	> Vetter Pharma: Governor of Illinois Opens the 2010 BIO International Convention	05/05/10
	> Vetter And Sentry Biopharma Services Establish Preferred Partnership Agreement	05/04/10
	> NiKem Research Receives Authorization for Rodent Toxicology Studies	05/03/10
	> Aragen Bioscience, Inc. and CEVEC Sign License Agreement for Human CAP and CAP-T Technology	04/30/10
	> Oncos Therapeutics Raises € 4 Million From Healthcap to Develop Oncolytic Viruses Into Cancer Treatments	04/29/10
	> BIOTECH CHINA 2010: Promoting Innovation and Business Contacts in China - The Market of The Future	04/28/10
	> GATC Subsidiary Lifecodexx AG Develops Tests for Prenatal Diagnostics	04/28/10
	> Probiogen Signs Therapeutic Protein Process Development Contract With Virdante Pharmaceuticals	04/28/10
	> Mucosis Appoints Dr. Roberto Grimaldi As Chief Medical Officer	04/27/10
	> New Co-ordinated Technical and Legal Services for Pharma and Biotech Companies	04/19/10
	> InVitria Sponsors the 2010 Cell Culture Engineering Conference	04/16/10
	> Vertical*i Presents New Business Development and Alliance Management Maximization Method at BIO2010	04/14/10
	> BioGenes Says Generic HCP Assays Provide Insufficient Sensitivity	04/14/10
	> Neurimmune Therapeutics AG Awarded the 2010 ZKB TECHNOPARK Pioneer Award	04/13/10
	> Critical Outcome Technologies Inc. Provides Update on HIV-1 Integrase Co-Development Program	04/13/10
	> NiKem Research Receives Qualification for Bioanalysis of Clinical Samples	04/13/10
	> Sloning Further Strengthens its Intellectual Property with New US Patent	04/13/10
	> Cleanroom Infrastructure Approaches Completion at Vetter's New Chicago Facility	04/06/10
	> Oral COTI-2 is Effective Against Aggressive Triple Negative Human Breast Cancer	03/30/10
	> Prosensa Initiates Clinical Development of PRO044 in an Open Label Phase I/II Study	03/30/10

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 3 of 10